Lifestyle and Pharmacological Interventions and Treatment Indications for the Management of Obesity in Children and Adolescents
- PMID: 37508727
- PMCID: PMC10378563
- DOI: 10.3390/children10071230
Lifestyle and Pharmacological Interventions and Treatment Indications for the Management of Obesity in Children and Adolescents
Abstract
Obesity is a multifactorial chronic impairment that further decreases quality of life and life expectancy. Worldwide, childhood obesity has become a pandemic health issue causing several comorbidities that frequently present already in childhood, including cardiovascular (hypertension, dyslipidemia), metabolic (Type 2 diabetes mellitus, fatty liver disease, metabolic syndrome), respiratory, gastrointestinal and musculoskeletal disorders. In addition, obese children frequently experience stress and psychosocial symptoms, including mood disorders, anxiety, prejudice and low self-esteem. Given that cardiovascular risk factors and pediatric obesity have the tendency to pertain into adulthood, obesity management, including weight control and physical activity, should start before the late teens and certainly before the first signs of atherosclerosis can be detected. This review aims to concisely present options for childhood obesity management, including lifestyle modification strategies and pharmacological treatment, as well as the respective treatment indications for the general practitioner.
Keywords: adolescents; childhood obesity; children; lifestyle; pharmacotherapy; treatment.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
The effectiveness of web-based programs on the reduction of childhood obesity in school-aged children: A systematic review.JBI Libr Syst Rev. 2012;10(42 Suppl):1-14. doi: 10.11124/jbisrir-2012-248. JBI Libr Syst Rev. 2012. PMID: 27820152
-
Bariatric surgery in the management of childhood and adolescence obesity.Endocrine. 2023 Mar;79(3):411-419. doi: 10.1007/s12020-022-03210-9. Epub 2022 Oct 4. Endocrine. 2023. PMID: 36194346 Review.
-
Severe Obesity in Children and Adolescents: Metabolic Effects, Assessment, and Treatment.J Obes Metab Syndr. 2021 Dec 30;30(4):326-335. doi: 10.7570/jomes21063. J Obes Metab Syndr. 2021. PMID: 34924365 Free PMC article. Review.
-
Review of Childhood Obesity: From Epidemiology, Etiology, and Comorbidities to Clinical Assessment and Treatment.Mayo Clin Proc. 2017 Feb;92(2):251-265. doi: 10.1016/j.mayocp.2016.09.017. Epub 2017 Jan 5. Mayo Clin Proc. 2017. PMID: 28065514 Review.
-
The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.JBI Database System Rev Implement Rep. 2015 Jan;13(1):88-98. doi: 10.11124/jbisrir-2015-1812. JBI Database System Rev Implement Rep. 2015. PMID: 26447010
Cited by
-
Assessing the impact of concurrent high-fructose and high-saturated fat diets on pediatric metabolic syndrome: A review.World J Clin Pediatr. 2024 Jun 9;13(2):91478. doi: 10.5409/wjcp.v13.i2.91478. eCollection 2024 Jun 9. World J Clin Pediatr. 2024. PMID: 38947987 Free PMC article. Review.
-
Editorial: Pediatric obesity: how to diverge from developmental pathways?Front Endocrinol (Lausanne). 2024 Jan 23;15:1363099. doi: 10.3389/fendo.2024.1363099. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38323111 Free PMC article. No abstract available.
-
Attendance-Based Adherence and Outcomes of Obesity Management Program in Arab Adolescents.Children (Basel). 2023 Aug 25;10(9):1449. doi: 10.3390/children10091449. Children (Basel). 2023. PMID: 37761410 Free PMC article.
-
The Ongoing Impact of COVID-19 on Pediatric Obesity.Pediatr Rep. 2024 Feb 2;16(1):135-150. doi: 10.3390/pediatric16010013. Pediatr Rep. 2024. PMID: 38391001 Free PMC article. Review.
-
Genetics, pharmacotherapy, and dietary interventions in childhood obesity.J Pharm Pharm Sci. 2024 May 28;27:12861. doi: 10.3389/jpps.2024.12861. eCollection 2024. J Pharm Pharm Sci. 2024. PMID: 38863827 Free PMC article. Review.
References
-
- NCD Risk Factor Collaboration (NCD-RisC) Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: A pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet. 2017;390:2627–2642. doi: 10.1016/S0140-6736(17)32129-3. - DOI - PMC - PubMed
-
- Olds T., Maher C., Zumin S., Péneau S., Lioret S., Castetbon K., de Wilde Bellisle J., Hohepa M., Maddiso R., Lissner L., et al. Evidence that the prevalence of childhood overweight is plateauing: Data from nine countries. Int. J. Pediatr. Obes. 2011;6:342–360. doi: 10.3109/17477166.2011.605895. - DOI - PubMed
-
- Daniels S.R., Arnet D.K., Eckel R.H., Gidding S.S., Hayman L.L., Kumanyika S., Robinson T.N., Scott B.J., St Jeor S., Williams C.L. Overweight in children and adolescents: Pathophysiology, consequences, prevention, and treatment. Circulation. 2005;111:1999–2012. doi: 10.1161/01.CIR.0000161369.71722.10. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources